Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
16,646 studies for “breast cancer”
Sponsor: National Cancer Institute (NCI)
Breast Cancer · Breast Carcinoma · Cancer of the Breast · Malignant Neoplasm of Breast
United States
Sponsor: UNC Lineberger Comprehensive Cancer Center
Breast Cancer
United States
Sponsor: University of Nottingham
Breast Cancer Female
United Kingdom
Sponsor: National Cancer Institute (NCI)
Breast Atypical Ductal Hyperplasia · Breast Atypical Lobular Hyperplasia · Breast Carcinoma · Breast Ductal Carcinoma In Situ
United States
Sponsor: Puma Biotechnology, Inc.
Hormone Receptor Positive HER-2 Negative Breast Cancer · Metastatic Breast Cancer · Recurrent Breast Cancer
United States, Portugal, Spain
Sponsor: Fore Biotherapeutics
Cancer Harboring BRAF Alterations · HGG · LGG · Solid Tumors
United States, Australia, Canada, France, Germany +7 more
Sponsor: Eli Lilly and Company
Metastatic Solid Tumor · Recurrent Solid Tumor · Advanced Solid Tumor · Urinary Bladder Neoplasm
United States, Australia, China, France, Japan +3 more
- Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast CancerActive Not Recruiting
Sponsor: Medical College of Wisconsin
Invasive Breast Cancer
United States
Sponsor: Avenzo Therapeutics, Inc.
HR+/HER2- Breast Cancer · HR+, HER2-, Advanced Breast Cancer
United States
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms · Triple Negative Breast Neoplasms · HR Low-Positive/HER2-Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +34 more
- A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast CancerRecruiting
Sponsor: AstraZeneca
Breast Cancer
United States, China, France, Italy, South Korea +1 more
- Genomic Services Research ProgramRecruiting
Sponsor: National Human Genome Research Institute (NHGRI)
Colon Cancer · Breast Cancer
United States
- Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast CancerNot Yet Recruiting
Sponsor: University of California, San Diego
Metastatic Invasive Breast Cancer · Resistant Breast Cancer · ER+, HER2-, Metastatic Breast Cancer
United States
Sponsor: Washington University School of Medicine
Breast Cancer · Cancer of Breast · Breast Neoplasms · Cancer of the Breast
United States
- Clinical Feasibility Study of Upright, Low-dose, High-resolution, 3D Breast CT (UBCT).Not Yet Recruiting
Sponsor: University of Arizona
Breast Cancer Detection
Sponsor: Novartis Pharmaceuticals
Breast Cancer · Non-small Cell Lung Cancer (NSCLC) · Gastric/Gastroesophageal Junction (GEJ) Cancer · Bladder Cancer
Australia, Canada, Japan
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +35 more
- Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast CancerCompleted
Sponsor: MedSIR
Breast Cancer · Triple Negative Breast Cancer
Spain
Sponsor: Hoffmann-La Roche
Metastatic Breast Cancer
United States, Argentina, Australia, Belgium, Brazil +24 more
Sponsor: Onchilles Pharma Inc
Neoplasms, Solid Tumor · Breast Neoplasms, Triple-Negative · Squamous Cell Carcinoma of Skin · Melanoma
United States, Australia
- Natural History Study of Early Life Exposures in Agriculture (ELEA)Enrolling By Invitation
Sponsor: National Cancer Institute (NCI)
Prostate Cancer · Leukemia · Breast Cancer · Melanoma
United States
- Safety and Tolerability of IPH4502 in Patients With Advanced Solid TumorsActive Not Recruiting
Sponsor: Innate Pharma
Advanced or Metastatic Solid Tumors
United States, France
- PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast CancerRecruiting
Sponsor: Abramson Cancer Center at Penn Medicine
Breast Cancer
United States
Sponsor: Merck Sharp & Dohme LLC
Triple Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +29 more
- Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant ChemotherapyActive Not Recruiting
Sponsor: ECOG-ACRIN Cancer Research Group
Estrogen Receptor Negative · HER2/Neu Negative · Invasive Breast Carcinoma · Progesterone Receptor Negative
United States, South Africa
16,646 studies found